OverviewSuggest Edit
Vapotherm develops and manufactures comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. The Company is an inventor of inventor of Hi-VNI® Technology.
| Type | Public | |
| Founded | 1999 | |
| HQ | Exeter, NH, US | Map |
| Website | vapotherm.com | |
| Employee Ratings | More |
Recent NewsAll News
- Use of High Velocity Nasal Insufflation in combination with servo controlled FiO2 delivery for the ambulation of a patient with severe Interstitial Lung Disease (ILD)
- Velocity – Ep 9 – Physicians discuss research on Mask-Free NIV for COPD patients
- How are Hospitals and Respiratory Care Departments Reimbursed for Respiratory Care Services?
- What Authority/Influence Do Respiratory Care Leaders Have with Regard to Productivity Measures and Benchmarking?
Key People/Management at Vapotherm
Joseph Army
President & Chief Executive Officer
John Landry
Vice President & Chief Financial Officer
Lindsay Becker
Vice President, Human Resources
David Blouin
Vice President, U.S. Sales
John Coolidge
Vice President, Operations
Jill Dooling
Vice President, Strategic Accounts
Vapotherm Office Locations
Vapotherm has an office in Exeter
Exeter, NH, US (HQ)
100 Domain Dr
Vapotherm Financials and Metrics
Vapotherm Revenue
Vapotherm's revenue was reported to be $48.10 m in FY, 2019
| USD | |
|---|---|
Revenue (Q3, 2020) | 30.6m |
Gross profit (Q3, 2020) | 15.5m |
Gross profit margin (Q3, 2020), % | 50.8% |
Net income (Q3, 2020) | (12.4m) |
EBIT (Q3, 2020) | (11.2m) |
Market capitalization (4-Dec-2020) | 697.2m |
Closing stock price (4-Dec-2020) | 27.2 |
Cash (30-Sept-2020) | 139.0m |
EV | 604.7m |
Vapotherm's current market capitalization is $697.2 m.
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.1m | 8.2m | 7.9m | 10.7m | 10.6m | 9.4m | 12.3m | 12.0m | 10.8m | 19.1m | 35.2m | 30.6m |
Cost of goods sold | 5.5m | 4.8m | 5.1m | 6.5m | 6.5m | 5.8m | 7.1m | 6.5m | 6.0m | 9.9m | 17.5m | 15.0m |
Gross profit | 3.6m | 3.4m | 2.8m | 4.2m | 4.1m | 3.6m | 5.2m | 5.5m | 4.8m | 9.2m | 17.6m | 15.5m |
Gross profit Margin, % | 40% | 41% | 35% | 40% | 39% | 39% | 42% | 46% | 44% | 48% | 50% | 51% |
Annual
Annual
Quarterly
| USD | Q3, 2017 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|
Net Income | (22.0m) | (29.6m) | (13.0m) | (25.8m) | (38.6m) | (13.8m) | (21.9m) | (34.3m) |
Depreciation and Amortization | 1.1m | 1.6m | 621.0k | 1.4m | 2.2m | 1.1m | 2.1m | 3.4m |
Inventories | (3.1m) | (1.1m) | 1.8m | 3.0m | 3.4m | (12.0k) | (9.2m) | (15.5m) |
Accounts Payable | (127.0k) | (336.0k) | (1.7m) | (1.6m) | (1.6m) | 1.3m | 3.4m | 2.8m |
| USD | FY, 2016 |
|---|---|
Financial Leverage | -0.3 x |
Vapotherm Cybersecurity Score
Vapotherm Environment, Social & Governance (ESG) Ratings
Vapotherm Online and Social Media Presence
908 Twitter followers
Vapotherm has 908 Twitter Followers. The number of followers has increased 0.1% month over month and increased 3.1% quarter over quarter
Vapotherm's Trends
Twitter Engagement Stats for @Vapotherm
864
Tweets
549
Following
908
Followers
9
Tweets last 30 days
0.6
Avg. likes per Tweet
33.3%
Tweets with engagement
Vapotherm Blogs
November 25, 2020
Use of High Velocity Nasal Insufflation in combination with servo controlled FiO2 delivery for the ambulation of a patient with severe Interstitial Lung Disease (ILD)
Thomas Hillmann, Respiratory Physiotherapist University of Essen, Ruhrlandklinik Vapotherm’s high velocity therapy is a tool for treating respiratory distress. Although individual results may vary, Vapotherm believes this case study is an example of the clinical benefit Vapotherm’s high velocity the…
November 20, 2020
Velocity – Ep 9 – Physicians discuss research on Mask-Free NIV for COPD patients
https://www.youtube.com/watch?v=rjoFMHPp3c4 Episode 9: Physicians discuss research on Mask-Free NIV for COPD patients In this episode, Dr. Kirk Hinkley interviews esteemed researcher and pulmonologist Dr. Charles Atwood about the latest research concerning use of high velocity therapy for COPD patie…
October 28, 2020
How are Hospitals and Respiratory Care Departments Reimbursed for Respiratory Care Services?
For most products, paying for a service or item is a simple transaction based on the listed price. The merchant posts the price, the consumer agrees, makes the payment, and gets the product. As healthcare providers, we are bombarded with the question: ‘Why can’t you operate like other businesses?’ T…
October 21, 2020
What Authority/Influence Do Respiratory Care Leaders Have with Regard to Productivity Measures and Benchmarking?
In talking with Respiratory Therapy leaders about productivity for more than a few years, their responses about their authority range from ‘none’ to ‘done’. Those replying that they have no authority indicate that administration has chosen the metric to use for each department and there is no possi…
October 14, 2020
What is Benchmarking and How are Performance Metrics Used for Benchmarking in the Context of RT Department Productivity?
In a previous blog, I went into detail about various metrics and how to assess the validity of metrics when examining Respiratory Department Productivity. Here I’m going to review commonly used metrics in our hospitals and define each, discuss the validity of each, and how to best capture and use t…
October 07, 2020
How are Respiratory Care Department Productivity Systems Captured and Tracked?
Having discussed the various performance metrics that are utilized in a previous blog, I’d like to discuss how these metrics are captured, tracked, and used within a Respiratory Care Department. The following questions will be addressed in this blog: Why metrics matter? How to evaluate the valid…
Vapotherm Frequently Asked Questions
When was Vapotherm founded?
Vapotherm was founded in 1999.
Who are Vapotherm key executives?
Vapotherm's key executives are Joseph Army, John Landry and Lindsay Becker.
How many employees does Vapotherm have?
Vapotherm has 279 employees.
What is Vapotherm revenue?
Latest Vapotherm annual revenue is $48.1 m.
What is Vapotherm revenue per employee?
Latest Vapotherm revenue per employee is $172.4 k.
Who are Vapotherm competitors?
Competitors of Vapotherm include ALung Technologies, Getinge and Trimedyne.
Where is Vapotherm headquarters?
Vapotherm headquarters is located at 100 Domain Dr, Exeter.
Where are Vapotherm offices?
Vapotherm has an office in Exeter.
How many offices does Vapotherm have?
Vapotherm has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies